To register for this live symposium:
Not able to attend in person?
Register for the live video stream:
*This video stream is a live broadcast of the symposium and can be viewed on a laptop or tablet.
Date and Location
This activity is supported by an educational grant from Sun Pharmaceuticals Industries, Inc.
The National Institute for Occupational Safety and Health is concerned about the risk and exposure of health care workers who handle, prepare, or administer hazardous drugs (HDs), such as chemotherapeutic agents, or those who work in areas where these drugs are used. Due to potential health risks associated with unintentional exposure to these agents, it is necessary to implement proper policies and procedures for safe handling, from delivery through disposal. Advancements in technology may help diminish exposure of HDs to health care professionals. This program will explain novel technologies and highlight best practices and appropriate measures to prevent unintentional exposure to HDs.
Type of Activity:
At the completion of this activity, the participant will be able to:
- Characterize the risks of unintentional exposure to chemotherapeutic agents
- Examine how dose banding and ready-to-administer technology may provide clinical and safety benefits
- Analyze novel technology that is available to prevent unintentional exposure to chemotherapeutic agents
No additional fee is required to attend this CPE-accredited symposium activity; however, registration to HOPA 2019 is required.
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.
Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Americans with Disabilities Act
Pharmacy Times Continuing Education™ (PTCE) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call 609-378-3701.
For questions about this live CPE activity, please contact: email@example.com
2 Clarke Drive | Cranbury, NJ 08512
P: 800.597.6372 | F: 609.228.5894
Marc Earl, PharmD
Assistant Director of Pharmacy
Department of Pharmacy
MiKaela Olsen, MS, APRN-CNS, AOCNS
Oncology and Hematology Clinical Nurse Specialist
Department of Oncology
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Hospital
Friday, April 5, 2019
Time*: 11:30 AM – 12:00 PM (Registration) | 12:00 PM – 1:00 PM (Main Session)
Fort Worth Convention Center
1201 Houston Street
Fort Worth, TX 76102
A Satellite Symposium to be conducted in conjunction with HOPA 2019.
||Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) under the ACPE universal activity number 0290-0000-19-061-L07-P. The activity is available for CE credit for April 5, 2019.
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Credit must be requested no later than June 5, 2019.
Faculty disclosures will be provided prior to the presentation.
The following contributors have no relevant financial relationships with commercial interests to disclose:
Marc Earl, PharmD.
Pharmacy Times Continuing Education™
Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy Seung, PharmD, BCOP; Crissy Wilson; Tiffany Fattizzi; Susan Pordon; and Brianna Winters.
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.